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The lipodistrofy in patients living with HIV / AIDS 
A lipodistrofia em pacientes que vivem com HIV/AIDS 
El lipodistrofia en los pacientes que viven con el VIH / SIDA 
 
Tiago Campos Armentano1, Alexandre Rosa da Silva2, Lorrana Vicente Ferrari3, Natalia Gonçalves 
Mateus4, Rosâne Mello5 
 
 
Objective: To discuss the relationship between the presence of lipodystrophy in patients with HIV / AIDS and 
outline actions that optimize quality of life better. Method: This is a research type of qualitative literature. Data 
collection was conducted during the months of July and August 2011, through the database of the Electronic 
Library of Brazilian Scientific Journals (SciELO Brazil) and pubmed. We use the following keywords for search: HIV 
/ AIDS and Lipodystrophy. Results: Based on reading the articles grouped the main changes related to 
lipodystrophy in three categories: 1) psychosocial changes, 2) bodily changes, and 3) metabolic disorders. 
Conclusion: Given the complexity of the effects caused by lipodystrophy, highlights the importance of 
multidisciplinary team with these clients and their families seeking comprehensive care and promote quality of 
life. Descriptors: Acquired immunodeficiency syndrome, Lipodystrophy, Nursing nutritional therapy, Physical 
Therapy. 
 
 
 
Objetivo: Discutir a relação entre a presença de lipodistrofia em pacientes portadores do vírus HIV/AIDS e 
esboçar ações que otimizem uma qualidade de vida melhor. Método: trata-se de uma pesquisa do tipo 
bibliográfica de natureza qualitativa. A coleta de dados foi realizada durante os meses de julho e agosto de 2011, 
através do banco de dados da Biblioteca Eletrônica de Periódicos Científicos Brasileiros (SciELO Brasil) e pubmed. 
Utilizamos os seguintes descritores para a busca: HIV/AIDS e Lipodistrofia. Resultados: Baseado na leitura dos 
artigos agrupamos as principais alterações relacionadas com a lipodistrofia em três categorias: 1) alterações 
psicossociais; 2) alterações corporais; e 3) alterações metabólicas.  Conclusão: Tendo em vista a complexidade 
das repercussões ocasionadas pela lipodistrofia, destaca-se a importância do trabalho da equipe multiprofissional 
com essa clientela e seus familiares, buscando a integralidade da assistência e promoção da qualidade de vida. 
Descritores: Síndrome de imunodeficiência adquirida, Lipodistrofia, Enfermagem terapia nutricional, 
Fisioterapia. 
 
 
Objetivo: Analizar la relación entre la presencia de lipodistrofia en pacientes con VIH / SIDA y las acciones de 
esquema que optimizan la calidad de vida mejor. MÉTODOS: Se trata de un tipo de literatura de investigación 
cualitativa. La recolección de datos se realizó durante los meses de julio y agosto de 2011, a través de la base de 
datos de la biblioteca electrónica de revistas científicas brasileñas (SciELO Brasil) y PubMed. Utilizamos las 
siguientes palabras clave para la búsqueda: VIH / SIDA y la lipodistrofia. Resultados: A partir de la lectura de los 
artículos agrupados los principales cambios relacionados con la lipodistrofia en tres categorías: 1) los cambios 
psicosociales, 2) los cambios corporales, y 3) trastornos metabólicos. Conclusión: Dada la complejidad de los 
efectos causados por la lipodistrofia, pone de relieve la importancia del equipo multidisciplinario con estos 
clientes y sus familias en busca de una atención integral y promover la calidad de vida. Descriptores: Síndrome 
de inmunodeficiencia adquirida, lipodistrofia, Terapia nutricional de enfermería, Terapia física. 
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The Acquired Immunodeficiency Syndrome (AIDS) is characterized by a severe dysfunction of 
the immune system of the individual infected with human immunodeficiency virus (HIV). Its clinical 
course is characterized by a considerable destruction of CD4 + T cells and can be divided into three 
stages: acute infection, asymptomatic infection, symptomatic disease. 
 Acute infection comes a few weeks after the initial infection and is difficult to diagnose 
because it resembles a common flu, or even a mononucleosis. In the second phase, the patient 
presents a picture of asymptomatic infection, which can last several years. The third phase, called 
symptomatic disease, the patient has several signs and symptoms such as prolonged fever, chronic 
diarrhea, weight loss, significant (greater than 10% of the previous weight of the individual), night 
sweats, fatigue and adenopathy. At this time, opportunistic infections begin to appear or reactivate 
such as tuberculosis, Pneumocystis carinii pneumonia, cerebral toxoplasmosis, candidiasis and 
cryptococci meningitis, among others. Rare tumors in immunocompetent individuals, such as Kaposi's 
sarcoma, non-Hodgkin lymphome can arise, characterizing AIDS. 
The natural history of the disease has been extensively modified by antiretroviral therapy 
(ART). This slows the progression of infection to its final stage, increasing the length and quality of life 
of people with the disease.¹ However, the reduction of morbidity and mortality from infectious 
diseases and neoplastic opportunists, have been watching the increasing prevalence of other diseases, 
including HIV-associated lipodystrophy.2 
The lipodystrophy syndrome is a clinical condition characterized by several changes, including 
the body. Highlighting the peripheral lipoatrophy, such as loss of fat in the face, arms, legs and 
buttocks and lipohypertrophy manifested by dorsocervical fat accumulation, increased waist 
circumference and increased volume of the breasts. In lipodystrophy, there are metabolic disorders 
such as insulin resistance, dyslipidemia and altered glucose metabolism.3 
It is believed that these changes are related to body use of anti-retroviral therapy, more 
specifically to the use of protease inhibitors.4 
The complexity of lipodystrophy, which ranges from physical changes to the prejudice 
involved, suggests the approach to the patient under the eyes of many professionals. The 
multiprofessional teamwork is characterized by the reciprocal relationship between multiple 
intervention techniques and interaction among agents of different professional areas.5 
Based on the above and in professional practice as residents entered into the Residency 
Program Multidisciplinary Health in a University Hospital located in Rio de Janeiro, the interest in 
addressing the issue. The group, composed of two nurses, a physiotherapist and a dietician, was faced 
with the complex reality faced by such patients during his time as residents with these clients. Being 
the clinic, the internal medicine ward, the ward clinical and surgical intensive care unit, parts of 
different scenarios experienced during our hospital practice. This paper aims to discuss the 
relationship between the presence of lipodystrophy in patients with HIV / AIDS and outline actions that 
optimize quality of life better. 
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This work it is a survey-type literature of qualitative nature. The qualitative approach in 
measuring variables is established to verify and explain their influence on others, based on the analysis 
of the frequency of incidents and statistical correlations.
6
 
A literature search using an extensive literature study and analyze various aspects of a topic, 
favoring more structured future research.
7
 
Data collection was conducted during the months of July and August 2011, through the 
database of the Electronic Library of Brazilian Scientific Journals (SciELO Brazil) and PubMed. We use 
the following keywords for search: HIV / AIDS and Lipodystrophy. 
The selection of articles was performed by reading the title and summary of all those surveyed 
in the database. We excluded studies that reading the summary had no relation with the topic in 
question, along with experimental studies. 
 
 
 
 
 
Based on reading the articles, we grouped the major changes related to lipodystrophy in three 
categories: 1) psychosocial changes, 2) bodily changes, and 3) metabolic abnormalities that can be 
seen in Table 1. 
Bodily Changes  Metabolic Changes Psychosocial Changes 
Central 
Lipohypertrophy 
Hypertriglyceridemia Difficulties in social 
relations 
Peripheral Lipoatrophy Hypercholesterolemia Difficulties in sexual 
relations 
Mixed Lipodystrophy Mixed Dyslipidemia Loss of self-esteem 
 Insulin resistance and / 
or diabetes mellitus type 
II 
Social isolation 
Table 1 - Major Changes observed in Lipodystrophy 
 
Psychosocial alterations 
 
With the bodily changes that cause the lipodystrophy syndrome in patients with HIV / AIDS on 
antiretroviral therapy, there may be psychological and emotional difficulties these people. We can 
visualize these difficulties in an article where the patients interviewed reported having difficulties in 
social relationships, such as social avoidance, difficulty in sexual relations due to not feel more 
sexually attractive, loss of self-image and reduced self-esteem, depression, and fear consequent 
forced disclosure of the diagnosis, the possible association of symptoms with the disease. However, the 
paper shows through its results, which family relationships and work are relatively not affected, and 
the family in general source of social support. In relation to work, approximately half of the 21 
participants were retired and did not use this modality as social networking.  
RESULTS  AND  DII SCUSSII ON  
METHODOLOGY  
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Those who worked reported that the fact of having the disease was unknown by his 
colleagues, who in turn reported the presence of signs of lipodystrophy generated embarrassment at 
work. This same study found that in general social relationships were unaffected by the presence of 
lipodystrophy. However, five participants reduced social contacts, complained of introversion and 
greater avoidance of occasions that involved meeting with people who knew them before the onset of 
lipodystrophy changes that entails. Also noteworthy is that most relationships are negatively affected 
loving in general for those without a steady partner.8 
Regarding the identification of lipodystrophy, most respondents reported that the first signs of 
the disease were weight loss of face. Regarding lipohypertrophy 16 people are reported to fat gain in 
the abdominal region.8 
It is also noteworthy that live with HIV / AIDS implies changes in behavior, lifestyle, habits, 
social and emotional impacts, constant use of medications, hospital visits applicants, besides the 
permanent coexistence with the impossibility of healing.9 
Adopting strategies as cosmetic procedures and plastic surgery, were identified as mitigating 
the consequences of lipodystrophy in relation to psychological well-being of these patients. Based on 
the above, Brazil has been a pioneer in offering free reconstructive surgeries for patients living with 
HIV / AIDS and use of antiretrovirals. This right, guaranteed by decree 2582 / GM December 2004, 
includes 8 table repair surgeries in the hospital information system SUS: a hump liposuction, 
liposuction of the abdominal wall, breast reduction, treatment of gynecomastia, fat grafting for 
buttock reconstruction gluteal fat tissue with tissue fillers, facial filling with polymethylmethacrylate 
(PMMA).10 
The article emphasizes that resort to plastic surgery, as well as being a way to reduce physical 
and aesthetic changes, helps in improving the psychological and social aspects involved, by removing 
signs that depict a stigmatizing disease, collaborating with well-being.9 
Body changes 
Based on the articles analyzed the bodily changes are frequently reported by patients 
themselves and later confirmed by clinical examination. The most common changes are the central 
lipohypertrophy (abdominal fat accumulation and / or trunk, breasts, dorsocervical region or also 
called buffalo-hump), peripheral lipoatrophy (fat atrophy ball of bichart, prominence of veins in the 
arm and leg) or mixed lipodystrophy (which include both changes).3, 11 
In a study that looked at the prevalence of lipodystrophy in 180 Brazilian adults, 57% of 
subjects reported some body alteration. A percentage of 43% of women noted more frequently in 
central lipohypertrophy, followed by mixed lipodystrophy in 40% of women. A percentage of 34% of 
men reported peripheral lipoatrophy, followed by mixed lipodystrophy in 34% of men and central 
lipohypertrophy in 32% of men.3    
In 2006, a study was conducted with 223 adults of both sexes in use of antiretroviral therapy 
(HAART) with protease inhibitor (PI) for at least three years. The aim of the study was to evaluate the 
association between dietary intake and the presence of abdominal obesity, defined by the ratio of 
waist and hip circumferences, as follows:> 0.95 for men and> 0.85 for women. The prevalence of 
abdominal obesity in the group was 45.7% and was associated with greater consumption of fat.3 
In a prospective cohort study conducted in Canada, from October 1998 to May 2001, with 366 
patients who started the first time the use of antiretroviral therapy, the presence of morphological 
changes and lipid was observed. There was an incidence of 29% for lipoatrophy, lipohypertrophy and 
23% to 13% for mixed lipodystrophy.11    
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Metabolic abnormalities 
In lipodystrophy, there are metabolic disorders such as insulin resistance, dyslipidemia and 
altered glucose metabolism.12 
A study performed in 176 patients with Minas Gerais, where 76% of users (ART) and 24% 
nonusers, sought to evaluate the use of ART and lipid and glycemic these patients. This study showed 
that HAART users had levels of triglycerides, total cholesterol and lipid fractions (HDL-cholesterol, 
LDL-cholesterol, VLDL-cholesterol) were significantly higher. Regarding fasting glucose values were not 
significant when the two groups were compared. But statistical significance when administered 75g of 
dextrose and glucose levels checked after 60 and 120 minutes. 
Another cross-sectional study aimed to assess the presence of lipodystrophy and its 
relationship with lipid profile and insulin resistance in thirty Brazilian children and adolescents on 
antiretroviral therapy with a median of 28.4 months at the time of the study. However, there were no 
statistically significant differences in any of the evaluated parameters (HOMA-IR, triglycerides, HDL-
cholesterol and LDL-cholesterol). 12 
Based on the changes described above suggest different actions aiming at improving the 
quality of life of these patients. 
 
Nursing actions 
Nursing assignments have to be worked both individually and collectively. Patients living with 
HIV / AIDS are more susceptible to opportunistic infections, underscoring the need for infection control 
measures, including the use of personal protective equipment by professionals. Such measures are 
general and should be applied in all patients. How to care more targeted to this audience we can cite 
the formulation of strategies by the multidisciplinary team for the realization of comprehensive care, 
the incentive for individuals to formulate a plan of life, encouraging the patient living with HIV / AIDS 
to take a stance front their lives and overcome the obstacles imposed by discrimination and prejudice, 
identification with the patient of their own potential and resources available in the community to 
meet their needs and information about their rights. Such care is facilitated by nursing staff contact 
with these patients over time. Thus favoring the creation of links, confidence and making it possible 
therapeutic communication. 
Regarding the identification with the patient about the resources available in the community, 
we can cite, for example, the existence of support groups. Such groups allow contact with other 
individuals facing similar problems. This is the space in which the individual verbalizes their fears, 
anxieties, worries and difficulties of everyday life. 
 The patient may also be informed about the Ordinance 2582/2004. 
Besides the concern for the patient, is crucial concern for their families. An illness in the 
family inserted can cause significant changes in household living, which may cause the risk of not 
adapting. Any family that demonstrates a difficulty in dealing with AIDS may need outside help and 
additional resources.14 
Nurses should stick to the complex family problem. This network of relationships requires an 
understanding that takes into account their integration in the socio-economic and cycle time lived.15 
The professional must be able to observe and recognize the role of the family to answer the 
health of their members, should consider the questions, opinions and actions of the family in proposing 
his actions. A family assistance entails knowing how each family cares and identifies difficulties and 
coordinates their efforts. Professionals should use their knowledge about each family and in 
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conjunction with each of them think and implement the best possível15 assistance based on 
information obtained. 
 
Shares of physiotherapy 
 
Besides the change in body fat distribution and metabolic changes, several other changes may 
occur in HIV-infected patients who use therapy (ART). Among them we can find orthopedic changes, 
the most common osteoporosis, osteopenia, carpal tunnel syndrome and adhesive capsulitis.16 
Osteoporosis and osteopenia are influenced multifactorial as activation of proinflammatory 
cytokines, direct action of the virus on bone cells, alterations in vitamin D metabolism and use of 
antiretroviral therapy, especially protease inhibitors. Knowing that the principal measure for 
preventing osteoporosis is the regular practice of physical activity and that HIV-infected patients who 
have lipodystrophy have a tendency to social isolation, is very important to promote regular physical 
activity individually or in groups, in order to prevent possible changes orthopedic and promote greater 
social interaction.16 
In this sense therapy comprises a primary support nutrition, it is necessary higher intake of 
calcium and even administration of vitamin D supplementation. 
According to a systematic review published in 2008, the group exercise programs promote 
greater socialization of these patients, an important instrument of social engagement and professional. 
Besides serving as a strategy for reducing cardiovascular risk in HIV-infected patients who present 
change in body fat distribution, also contributing to the increase in insulin sensitivity. The author 
describes the importance of performing a multidisciplinary approach for the treatment of these 
patients in order to promote a better quality of life.17 
 
Shares of nutrition 
From a nutritional standpoint, few articles related to the management of patients with 
lipodystrophy are found in the literature. However, in clinical practice we observed that this 
population often develops metabolic syndrome (MS). A complex and multifactorial disorder that is 
associated with increased cardiometabolic diseases.18 
According to the American Heart Association and the National Heart, Lung, and Blood Institute 
(AHA/NHLBI- 2005) the diagnosis of MS is determined by the presence of three or more of the following 
conditions: abdominal obesity (measured by waist circumference values exceeding 102 cm and 88 cm 
in men and women, respectively), hypertension (defined as blood pressure equal to or greater than 
130/85 mmHg), impaired glucose tolerance or diabetes mellitus (fasting glucose greater than or equal 
to 100 mg / dl) , hypertriglyceridemia (values equal to or above 150 mg / dl) and low blood 
concentrations of HDL-C (less than 40 mg / dl for men and 50 mg / dl for women).19 
 
Recommendations macronutrients 
The recommendation of carbohydrates should be between 50 to 60% of the total caloric value 
(TCV), which prioritized the complex, such as whole grains, fruits and vegetables.20 
The fibers are complex carbohydrates that are classified according to their solubility. Soluble 
fibers are represented by pectin (fruit) and the gums (oats, barley and legumes) and are related to 
reduced gastrointestinal transit and control of dyslipidemia. Regarding the insoluble fibers, they do not 
act on the cholesterol, but increase satiety and accelerate gastrointestinal transit. Represented by 
cellulose (wheat), hemicellulose (grains) and lignin (vegetables). The daily recommendation of fiber 
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for adults is 20 to 30 g, and 5 to 10g soluble fiber, as an additional measure for reduction of 
cholesterol.20 
It is recommended protein intake of 0.8 to 1.0 g / kg current or 15% of total caloric value. 
Although hyperprotein diets and low-carbohydrate concentrations can promote weight loss and 
improve glucose in the short term, its effectiveness is not well established long term.21 
Regarding the ingestion of lipids, their intake should range between 25 and 35% of the VCT, 
with less than 7% saturated fat, 10% and 20% polyunsaturated and monounsaturated up to 200 mg / day 
of cholesterol.22 
The omega-3 is associated with decreased triglyceride levels, decreased platelet aggregation 
and blood pressure while minimizing the risk of CHD and increasing insulin sensitivity.20 
 
Additional recommendations 
The consumption of sodium chloride should be limited to 6g/day or 2400 mg of sodium and 100 
meq / day of sodium. Should be avoided processed foods like sausages, canned, smoked and canned. 
Natural seasonings like parsley, chives and herbs are recommended instead of industrialized 
condiments.21 
Excessive consumption of alcohol raises blood pressure and can also cause a resistance 
antihypertensive therapy. In general, the use of alcoholic beverages must be inadvisable to 
hypertensive subjects, hypercholesterolemia and aimed at weight loss, since each gram of alcohol is 
7.0 kcal. In the case of those who choose to consume alcohol, it is advisable that consumption does not 
exceed 30 ml of ethanol / day. This corresponds to 60 ml of liquor, wine of 240 ml or 720 ml beer. For 
women, the dosage should not be above 15 g ethanol / day.23 
Given the changes in lipid profile and high prevalence of overweight and obesity in individuals 
with metabolic syndrome, there is a need for supplementation of antioxidant nutrients to combat 
oxidative stress. These include vitamins A, C and E, copper, selenium and zinc. Planning is needed 
nutrition education associated with these measures, aiming to control the syndrome and preventing 
the rise of co-morbidities.24 
The adoption of model DASH diet (Dietary Approaches to Stop Hypertension) Diet and the 
Mediterranean which recommend the use of vegetables, legumes, whole grains, fruits, dairy products 
low in total fat, saturated fat, cholesterol and trans, high amount of monounsaturated fat (olive oil) 
and omega-3 and provide high amounts of potassium, magnesium and calcium may be a therapeutic 
option in metabolic syndrome when associated with a lifestyle intervention.25 
Weight loss is more effective when regular exercises are daily. The basic recommendations 
include aerobic exercise, lasting 30 to 60 minutes per day. Besides helping in losing weight, regular 
physical activity is associated with improved insulin resistance, reduction in blood pressure levels and 
increased HDL-cholesterol. The goal of treatment is a weight loss of about 7% to 10% of body weight in 
a period of 6 to 12 months. The recommended speed for slimming should be 2-4 kg per month.26 
 
 
 
 
Given the complexity of the effects caused by lipodystrophy, especially coping with the 
physical and emotional suffering, which ultimately lead to social isolation, highlights the importance of 
multidisciplinary team with these clients and their families seeking comprehensive care and enhancing 
the quality of life. 
CONCLUSII ON  
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Due to the lack of national studies that address this issue, we emphasize the importance of 
further studies in the area, especially studies that address the role of the multidisciplinary team in the 
care of these patients. 
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